Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis: its diagnosis, its consequences]

P Hardouin1

  • 1Institut de Recherche sur les Maladies du Squelette, Institut Calot, Berck sur Mer.

Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
|February 21, 1998
PubMed
Summary

Osteoporosis is a bone disease increasing fracture risk, especially after menopause in women. Treatments include estrogen therapy, calcium, sodium fluoride, and bisphosphonates to prevent bone loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implication of fatty acids in the inhibitory effect of human adipocytes on osteoblastic differentiation.

Bone·2013
Same author

IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling.

Cytokine·2010
Same author

TNF-α stimulates alkaline phosphatase and mineralization through PPARγ inhibition in human osteoblasts.

Bone·2010
Same author

Do cytokines induce vascular calcification by the mere stimulation of TNAP activity?

Medical hypotheses·2010
Same author

TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.

Life sciences·2009
Same author

Gene expression in normotopic and heterotopic human bone: increased level of SP7 mRNA in pathological tissue.

Molecular and cellular biochemistry·2008

Area of Science:

  • Metabolic bone disease research.
  • Endocrinology and gerontology.

Context:

  • Osteoporosis is a significant health concern, increasing fracture risk.
  • Postmenopausal women are particularly susceptible due to bone loss.
  • Common fracture sites include hip, wrist, and vertebrae.

Purpose:

  • To outline the characteristics and risk factors of osteoporosis.
  • To discuss preventative measures and therapeutic interventions for osteoporosis.

Summary:

  • Osteoporosis is a metabolic bone disease marked by elevated fracture risk.
  • Estrogen replacement therapy can prevent postmenopausal bone loss.
  • Calcium intake, sodium fluoride, and bisphosphonates are key treatments.

Impact:

  • Informs on osteoporosis management strategies.
  • Highlights the importance of early intervention and treatment.
  • Aids in understanding osteoporosis in postmenopausal women.

Related Experiment Videos